Long-Term Follow-Up of Resistance-Associated Substitutions in Hepatitis C Virus in Patients in Which Direct Acting Antiviral-Based Therapy Failed

We evaluated the transition of dominant resistance-associated substitutions (RASs) in hepatitis C virus during long-term follow-up after the failure of DAAs (direct acting antivirals)-based therapy. RASs in non-structure (NS)3/4A, NS5A, NS5B, and deletions in NS5A from 20 patients who failed simepre...

Descripción completa

Detalles Bibliográficos
Autores principales: Yoshida, Kanako, Hai, Hoang, Tamori, Akihiro, Teranishi, Yuga, Kozuka, Ritsuzo, Motoyama, Hiroyuki, Kawamura, Etsushi, Hagihara, Atsushi, Uchida-Kobayashi, Sawako, Morikawa, Hiroyasu, Enomoto, Masaru, Murakami, Yoshiki, Kawada, Norifumi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454875/
https://www.ncbi.nlm.nih.gov/pubmed/28467359
http://dx.doi.org/10.3390/ijms18050962

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5454875/
https://www.ncbi.nlm.nih.gov/pubmed/28467359
http://dx.doi.org/10.3390/ijms18050962

Ejemplares similares